Nn6018-7527
Research payments
$636,994
Through program year 2024, $636,994 in research payments was reported against Nn6018-7527, across 454 payments, paid by Novo Nordisk Inc.
- Paid by
- Novo Nordisk Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $636,994 | 454 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Sharan Mahal Bridgewater, NJ Named on 100 payments
- Jason Zelenka Clearwater, FL Named on 85 payments
- Ashit Jain Fremont, CA Named on 76 payments
- Faisal Wahid McKinney, TX Named on 67 payments
- Theodore Pope Overland Park, KS Named on 31 payments
- Pablo Pergola San Antonio, TX Named on 28 payments
- Babak Hassid New York, NY Named on 23 payments
- Neil Kumar Rochester, MN Named on 21 payments
- Matthew Budoff Torrance, CA Named on 10 payments
- Franklin Handel Miamisburg, OH Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.